(1mg) Rasagiline "''

Rasagiline (1mg)
Rasagail 1.0  

Rasagiline, commonly known by its brand name Rasagail 1.0, is a medication primarily used in the management of Parkinson's disease. This article delves into the uses, mechanisms of action, dosage, side effects, and important safety information regarding Rasagiline. By providing a thorough overview, we aim to enhance understanding of this vital medication for both healthcare professionals and patients.

What is Rasagiline?

Rasagiline is a selective monoamine oxidase type B (MAO-B) inhibitor. This classification of drugs works by preventing the breakdown of dopamine in the brain, which is crucial for regulating movement and coordination. Dopamine is a neurotransmitter that plays a significant role in mood, behavior, and motor control. In Parkinson's disease, the levels of dopamine are severely reduced, leading to the characteristic symptoms such as tremors, rigidity, and bradykinesia (slowness of movement).

How Does Rasagiline Work?

Rasagiline acts by selectively inhibiting the enzyme monoamine oxidase B. This enzyme is responsible for the oxidative deamination of neurotransmitters, including dopamine. By inhibiting MAO-B, Rasagiline increases the levels of dopamine available in the brain, thereby enhancing dopaminergic transmission. This leads to improved motor function and alleviation of the symptoms associated with Parkinson's disease.

Mechanism of Action:

1. Inhibition of MAO-B: Rasagiline selectively blocks the action of the MAO-B enzyme, reducing the breakdown of dopamine and other monoamines.
2. Increased Dopamine Levels: By preventing the degradation of dopamine, Rasagiline helps sustain higher levels of this critical neurotransmitter.
3. Neuroprotective Effects: Emerging evidence suggests that Rasagiline may exert neuroprotective effects, potentially slowing the progression of Parkinson's disease.

Uses of Rasagiline

Rasagiline is primarily indicated for the treatment of:

• Parkinson's Disease: It can be used as a monotherapy (on its own) in the early stages of the disease or as an adjunctive treatment with levodopa in advanced stages. It helps manage the motor symptoms associated with Parkinson's disease, including:
  • Tremors
  • Rigidity
  • Bradykinesia
  • Postural instability

Additionally, Rasagiline may provide benefits in improving overall quality of life for patients with Parkinson's disease.

Dosage and Administration

The dosage of Rasagiline should be individualized based on the patient's clinical response and tolerability. Here are general guidelines:

• Initial Dose: The typical starting dose is 1 mg once daily.
• Maintenance Dose: The dose may be increased to 2 mg per day, depending on the patient's response and tolerance.
• Administration: Rasagiline can be taken with or without food. It is important to swallow the tablet whole without crushing or chewing.

Important Considerations:

• Adjustment in Renal Impairment: Dose adjustments may be necessary for patients with severe renal impairment.
• Drug Interactions: Caution should be exercised when prescribing Rasagiline with other medications, particularly those that can increase serotonin levels (e.g., SSRIs, SNRIs).

Side Effects

While Rasagiline is generally well-tolerated, some patients may experience side effects. Common side effects include:

• Headache
• Dizziness
• Nausea
• Insomnia
• Abdominal pain

Serious Side Effects:

Patients should be aware of potential serious side effects, including:

• Hypertensive Crisis: Due to its MAO-inhibiting properties, Rasagiline can lead to dangerously high blood pressure if taken with certain foods (rich in tyramine) or medications.
• Serotonin Syndrome: Concurrent use with other serotonergic drugs can increase the risk of serotonin syndrome, a potentially life-threatening condition.

Safety Information and Precautions

• Tyramine-Rich Foods: Patients should avoid foods high in tyramine, such as aged cheeses, cured meats, and fermented products, as these can cause a hypertensive crisis.
• Medical History: Inform your healthcare provider about any history of cardiovascular issues, liver disease, or psychiatric disorders.
• Pregnancy and Lactation: The safety of Rasagiline during pregnancy and breastfeeding has not been established. It should only be used if the potential benefits outweigh the risks.

Conclusion

Rasagiline (Rasagail 1.0) represents a vital therapeutic option in the management of Parkinson's disease. By increasing dopamine levels in the brain, it alleviates the motor symptoms associated with the condition and improves patients' quality of life. Understanding its uses, mechanisms of action, potential side effects, and necessary precautions is essential for optimal treatment outcomes. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488 

BUY NOW